Orchestra BioMed Holdings, Inc. (OBIO)

Orchestra BioMed Holdings Statistics

Total Valuation

OBIO has a market cap or net worth of $219.76 million. The enterprise value is $142.79 million.

Market Cap	219.76M
Enterprise Value	142.79M

Important Dates

The next estimated earnings date is Tuesday, November 19, 2024, after market close.

Earnings Date	Nov 19, 2024
Ex-Dividend Date	n/a

Share Statistics

OBIO has 37.82 million shares outstanding. The number of shares has increased by 66.07% in one year.

Current Share Class	37.82M
Shares Outstanding	37.82M
Shares Change (YoY)	+66.07%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	3.19%
Owned by Institutions (%)	21.23%
Float	17.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	93.25
Forward PS	57.20
PB Ratio	4.43
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	68.68
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.58, with a Debt / Equity ratio of 0.03.

Current Ratio	4.58
Quick Ratio	4.50
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -83.22% and return on invested capital (ROIC) is -49.69%.

Return on Equity (ROE)	-83.22%
Return on Assets (ROA)	-36.75%
Return on Capital (ROIC)	-49.69%
Revenue Per Employee	$37,125
Profits Per Employee	-$992,446
Employee Count	56
Asset Turnover	0.02
Inventory Turnover	1.34

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.40% in the last 52 weeks. The beta is 0.41, so OBIO's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+4.40%
50-Day Moving Average	5.45
200-Day Moving Average	6.15
Relative Strength Index (RSI)	49.70
Average Volume (20 Days)	46,260

Short Selling Information

The latest short interest is 826,071, so 2.18% of the outstanding shares have been sold short.

Short Interest	826,071
Short Previous Month	911,873
Short % of Shares Out	2.18%
Short % of Float	4.72%
Short Ratio (days to cover)	11.96

Income Statement

In the last 12 months, OBIO had revenue of $2.08 million and -$55.58 million in losses. Loss per share was -$1.57.

Revenue	2.08M
Gross Profit	1.91M
Operating Income	-58.29M
Pretax Income	-51.64M
Net Income	-55.58M
EBITDA	-58.00M
EBIT	-58.29M
Loss Per Share	-$1.57

Balance Sheet

The company has $65.18 million in cash and $1.45 million in debt, giving a net cash position of $63.73 million or $1.68 per share.

Cash & Cash Equivalents	65.18M
Total Debt	1.45M
Net Cash	63.73M
Net Cash Per Share	$1.68
Equity (Book Value)	44.13M
Book Value Per Share	1.23
Working Capital	51.98M

Cash Flow

In the last 12 months, operating cash flow was -$44.58 million and capital expenditures -$131,000, giving a free cash flow of -$44.71 million.

Operating Cash Flow	-44.58M
Capital Expenditures	-131,000
Free Cash Flow	-44.71M
FCF Per Share	-$1.18

Margins

Gross Margin	92.02%
Operating Margin	-2,803.61%
Pretax Margin	-2,673.26%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-2,026.67%

Dividends & Yields

OBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-66.07%
Shareholder Yield	-66.07%
Earnings Yield	-26.91%
FCF Yield	-21.65%

Analyst Forecast

The average price target for OBIO is $15.75, which is 171.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.75
Price Target Difference	171.08%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	63.03%
EPS Growth Forecast (5Y)	-18.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OBIO has an Altman Z-Score of -2.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.19
Piotroski F-Score	1